Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on 2 Aryl Ortho Substituted Triethyl Silicon Pyridine. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN109651421B details a cost-effective Ru-catalyzed C-H silylation. Offers high yields up to 85% for pharmaceutical intermediates, ensuring reliable supply chain stability.
Novel ruthenium-catalyzed C-H silylation method offers cost-effective production of high-purity pharmaceutical intermediates with simplified one-pot processing.